Navigation Links
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Date:12/15/2008

alidated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about APD597's development, therapeutic indication, efficacy and potential; the potential of the GDIR, including the potential to stimulate insulin release in response to increases in blood glucose; future activities under Arena's collaboration with Ortho-McNeil; the protocol, design, scope, enrollment and other aspects of the Phase 1 program for APD597; the inclusion of the evaluation of patients with type 2 diabetes in the planned clinical studies; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents an
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Deutschland, 31. Juli 2014  invendo medical ... („robotischen") Koloskopie-Systems für den Einmalgebrauch, verkündete heute, ... weltweit anerkannter Manager im Bereich Medizintechnik, als ... stößt. Logo - ... hochangesehener globaler Visionär der Medizintechnikbranche. Er war ...
(Date:7/31/2014)... , July 31, 2014  Celsion Corporation (NASDAQ: ... host a conference call to discuss its second quarter ... August 7, 2014. To participate in the call, interested ... ) or 1-785-830-1924 (International/Toll) and ask for the Celsion ... to register ten minutes before the call is scheduled ...
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
Breaking Medicine Technology:invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32
... 2011 Reportlinker.com announces that a new ... catalogue: The Changing Role ... http://www.reportlinker.com/p0574968/The-Changing-Role-of-Natural-Products-in-Drug-Discovery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development ... reveals how natural products have been of ...
... LOS ANGELES, July 18, 2011 The transformative power of ... were first introduced in the market. When cosmetic laser treatments ... of skin off the face to reveal smoother, younger skin ... that they could only work from the top of the ...
Cached Medicine Technology:The Changing Role of Natural Products in Drug Discovery 2The Changing Role of Natural Products in Drug Discovery 3The Changing Role of Natural Products in Drug Discovery 4Renaissance Laser and Vein Institute Specializes in Revolutionary Laser Treatments for a Variety of Cosmetic Applications 2
(Date:7/31/2014)... CAMBRIDGE, Mass. (July 31, 2014) Long associated ... ancient cellular survival response regulated by Heat-Shock Factor ... their environment into co-conspirators that support malignant progression ... Institute scientists this week in the journal ... with significant implications for the diagnosis, prognosis, and ...
(Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... Market Research, "Orthopedic Trauma Fixation Devices Market - Global ... - 2020," the global orthopedic trauma fixation devices market ... is expected to grow at a CAGR of 7.2% ... of USD 9.3 billion in 2020. Globally, the orthopedic ...
(Date:7/31/2014)... This news release is available in German ... The insular cortex is an integral "hub", combining ... in insular structure and function have been reported ... depression, addiction and autism spectrum disorders (ASD). Scientists ... Neurobiology in Martinsried now describe consistent alterations in ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... the colorants market in North America with analysis ... the TOC of the North American Colorants Market ... analysis provided. This also provides a glimpse of ... and is supported by various tables and figures. ...
(Date:7/31/2014)... virus that causes cold sores -- herpes simplex type 1 ... to a new study. Researchers in Australia found ... with the virus. This explains why some people with the ... only occasionally. The authors said the findings could lead to ... the disease was dormant, it was a truce. It turns ...
Breaking Medicine News(10 mins):Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 2Health News:Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi 3Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 2Health News:Orthopedic Trauma Fixation Devices Market: Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 3Health News:Insular cortex alterations in mouse models of autism 2Health News:Insular cortex alterations in mouse models of autism 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2
... abnormal brain activity, researchers say , THURSDAY, Feb. 18 ... illness known as generalized anxiety disorder, a new study ... ways. , The study authors say the research ... suffering from debilitating anxiety. , "Patients experience anxiety ...
... ... Centers for Knee and Hip Replacement are part of the Blue Cross and Blue Shield ... ... has designated Abington Memorial Hospital as a Blue Distinction Center for Spine Surgery ...
... ... his new Authentic/Biblica book, Talking Smack , ... (PRWEB) February 18, 2010 -- Are you talking smack? You’d better be., , ... who has worked with parents and teens for more than 20 years and created the ...
... ... to begin an online journey, find the right ways to embrace this new communication environment ... ... of change for communicators everywhere. After a devastating recession in 2009, this year has ...
... ... delivery errors while protecting patients and caregivers. , ... Ferndale, MI (PRWEB) Feb. 18, 2010 ... of the Enovate Medication Cart, the newest addition to its medical cart series. ...
... ... (PCBs) and PCB engineering and design services, announces the availability of specialized PCBs for ... develop medical electronic printed circuit assemblies. , ... Chicago, IL (PRWEB) February 18, 2010 -- Electronic ...
Cached Medicine News:Health News:Anxiety Disorder Patients Process Emotions Differently 2Health News:Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM) 2Health News:Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM) 3Health News:Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM) 4Health News:Talking Smack to Keep Kids Drug-Free 2Health News:Talking Smack to Keep Kids Drug-Free 3Health News:Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters 2Health News:Enovate Announces New Lightweight Medication Cart Series 2Health News:Enovate Announces New Lightweight Medication Cart Series 3Health News:Electronic Interconnect Offers Medical Electronics, PCBs, Design Engineering 2Health News:Electronic Interconnect Offers Medical Electronics, PCBs, Design Engineering 3
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Jerome Halo Traction Units provide optimum immobilization for unstable injuries of the spine. The Generation 80 superstructure is available with either 2-point (serrated disk), or 3-point (flexion/ex...
... Boston Scoliosis Brace™ for neuromuscular ... a lightweight, soft, and easy ... maximum comfort. The Soft ... of non-cracking orthopedic grade copolymer ...
An indirect immunofluorescence antibody test for the qualitative and semi-quantitative detection of endomysial antibodies (EMA) in human serum as an aid in the diagnosis of celiac disease and dermati...
Medicine Products: